Word Doctoring: Telling It How It Is

REKENTHALER REPORT: The fund industry is counselled on messaging by Invesco…and Morningstar’s John Rekenthaler

John Rekenthaler 25 June, 2013 | 9:52AM
Facebook Twitter LinkedIn

Say What?

Now here's an intriguing headline: "Invesco Reveals Worst Words to Use with Investors." (The article from Ignites is behind a paywall, sorry.) What's more, the source of Invesco's insights was research from a firm where my former college roommate, the (in)famous Frank Luntz, once worked (maslanksy + partners, formerly maslansky luntz + partners). One needn't agree with Frank's politics to acknowledge that the author of the term "death tax" is a master at messaging and that his former firm probably has a knack too. What Orwellian language did the consultants suggest for fund companies?

Not much--at least as publicly disclosed by Invesco, the findings are noncontroversial. But they are useful. Consider the tricky item of informing fund investors about what they pay. A test audience was asked which it would least enjoying paying: fees, commissions, charges or costs. Respondents were nine times more likely to say fees rather than costs. After all, the first three items sound like mechanisms for boosting fund-company profits. Also, they are arbitrary. A fee, commission or charge is set at the level that a fund company desires. Costs, on the other hand, merely imply what the fund company must recover to pay its bills.  It's only fair that the companies be able to recoup their costs of operation, no?

Another subtlety was the perceived difference between "straightforward" and "transparent." The two words are often used interchangeably, but per Invesco's research they should not. Respondents greatly preferred the word straightforward. If they were told that fees--oops, costs--were presented to them in a straightforward fashion, they tended to believe that statement. If, on the other hand, they were told that the costs were transparent, they figured that something might be hidden. (Transparent is redolent of a magic trick. "See, a clear pane of glass, there's nothing behind here ...")

The most useful advice for Morningstar writers and *cough* daily columnists is to use more words to explain an idea rather than to slip into jargon. The given example is "managing longevity risk," a phrase that almost nobody in the test audience understood or liked. When reworded as "making sure you have enough money as long as you live," the audience was much happier.  A good lesson, that. Not that I will always have the discipline to remember and follow it, but I'll try.

The Tough Questions

Morningstar's Christine Benz spots me. "Why do fund companies charge more for a new fund when there's no extra investment work?," she asks. I ask her what she means. She tells me of a fund company that is launching a global fund. The portfolio will splice the fund company's existing US fund with its existing international fund. Thus, there will be no additional investment expenditures. However, the new fund's expense ratio is not lower than that of the existing funds, which after all have already hired investment staff. In fact, the new fund charges more.

Oh, Christine. Those are not charges. Nor are they fees. They are costs. Just because you can't see what the fund company spends, doesn't mean that the costs aren't there.  After all, the risk oversight committee still needs to oversee that new fund, and a portfolio manager must review its trades, and … [Waves hands animatedly, while slowly backing out of the room.]

Alright, I don't have much of an answer. Nor do I have a response for Christine's query of why small-company funds have higher management fees than large-company stock funds, even as the small-company funds tend to be assigned the firm's junior researchers. Ask the hard ones of somebody else, Christine.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

John Rekenthaler

John Rekenthaler  John Rekenthaler is vice president of research for Morningstar.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures